ReviewCureus2025
Schizophrenia: What We Know and What We Are Yet to Know.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Schizophrenia is an intricate mental disorder characterized by psychosis. The condition typically emerges during late adolescence and early adulthood, often persisting throughout a lifetime. The condition is understood to arise from a complex interplay of genetic, neurobiological, and environmental factors. This systematic review aimed to synthesize the extant knowledge state on schizophrenia through critical appraisal and integration of evidence from various domains, including neurobiology, genetics, clinical manifestations, therapeutic interventions, and environmental risk factors. We conducted an in-depth literature search on various medical databases, including PubMed, Medline, Scopus, and Google Scholar, for peer-reviewed articles focusing on schizophrenia. The study findings indicate that schizophrenia is a highly heterogeneous disorder attributable to complex interactions between neurobiological, genetic, and environmental factors, which make its diagnosis and treatment difficult. In our future studies, we intend to focus on interdisciplinary approaches and translation of molecular discoveries into clinical practice to improve diagnosis and treatment interventions, as well as reduce the schizophrenia burden.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.